IM8 Health Expands Scientific Advisory Board with New Experts

IM8 Health Expands Scientific Advisory Board with New Experts

IM8, the premium supplements brand co-founded by David Beckham, has announced the addition of two distinguished new members, Dr. Jeremy London and Dr. Amy Shah, to its world-class Scientific Advisory Board (SAB). This move underscores IM8’s commitment to leading innovation in science, longevity, and human performance.

The newly appointed members are:

• Dr. Amy Shah – An acclaimed integrative medicine physician, Dr. Shah focuses on gut health and nutrition. Her evidence-based approach will guide IM8’s development of wellness solutions.
• Dr. Jeremy London – A board-certified cardiothoracic surgeon specializing in preventive cardiovascular health, Dr. London’s expertise will enhance IM8’s initiatives in cardiovascular health products.

Danny Yeung, co-founding partner and CEO of IM8, stated, ‘Our Scientific Advisory Board has been instrumental since day one in helping us set industry-leading standards. We’re eager to welcome Dr. London and Dr. Shah, whose exceptional expertise will elevate our innovative research and product development even further.’

The SAB, established since IM8’s inception, features top experts including Dr. Dawn Mussallem from Mayo Clinic, former NASA Chief Scientist Dr. Jim Green, and others, all contributing to the company’s product development.

IM8’s flagship product, Daily Ultimate Essentials, reflects the SAB’s foundational role. This daily powder supplement is designed to enhance energy and overall health, supported by rigorous clinical trials.

The global supplements market is projected to reach $300 billion by 2028, driven by increasing consumer demand for scientifically-backed products.